ZAMPILIMAB
UNII 52B38H09GZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Zampilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 52B38H09GZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2098280-42-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
52B38H09GZ
CAS Registry Number
2098280-42-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZAMPILIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166806
National Cancer Institute reference terminology for clinical and research data.
INN ID
10843
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zampilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZAMPILIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN TISSUE TRANSGLUTAMINASE) (HUMAN-MUS MUSCULUS MONOCLONAL UCB7858 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL UCB7858 .KAPPA.-CHAIN, DIMER
ZAMPILIMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus